Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Disposal of unused meds
Orfadin® (nitisinone) - product information

Orfadin® (nitisinone)

Overview | Product information | Accredo services | Contact team


Orfadin is indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type I.

For more information, please download the full prescribing information.


Orfadin is a registered trademark of Sweden Orphan International AB and is distributed by Rare Disease Therapeutics, Inc.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us